Ology Bioservices® is now part of Resilience (National Resilience, Inc.). Resilience is a first-of-its-kind manufacturing and technology company offering a network of high-tech, end-to-end manufacturing solutions including production of cell and gene therapies, viral vectors, oncolytic viruses and vaccines. Resilience offers the highest quality and regulatory capabilities with support from IND through Licensure, along with flexible and adaptive facilities to serve partners of all sizes. For more information, visit www.resilience.com. To reserve capacity for 2021 productions, go to www.ologybio.com/reserve or contact one of our BD representatives.